Svetlana V. Papizh

Svetlana V. Papizh

Auto-generated profile, based on publicly available information

Svetlana V. Papizh

Veltischev Research and Clinical Institute for pediatrics and pediatric surgery at the Pirogov Russian National Research Medical University

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 April 2018 in Clinical Journal of the American Society of Nephrology
Verified
Journal Article
Closed access
PDF file
LMLaura Massella
Laura Massella
DMDjalila Mekahli
Djalila Mekahli
DPDušan Paripović
Dušan Paripović
LPLarisa Prikhodina
Larisa Prikhodina
NGNathalie Godefroid
Nathalie Godefroid
FEFrancesco Emma
Francesco Emma
Background and objectives: Autosomal dominant polycystic kidney disease is the most common inheritable kidney disease, frequently thought to become symptomatic in adulthood. However, patients with autosomal dominant polycystic kidney disease may develop signs or symptoms during childhood, in particular hypertension. Although ambulatory BP monitoring is the preferred method to diagnose hypertension in pediatrics, data in children with autosomal dominant polycystic kidney disease are limited. Design, setting, participants, & measurements: Our retrospective multicenter study was conducted to collect ambulatory BP monitoring recordings from patients with autosomal dominant polycystic kidney disease age 1 cm per kidney and daytime hypertension (odds ratio, 1.70; 95% confidence interval, 1.21 to 2.4; P=0.002), nighttime hypertension (odds ratio, 1.31; 95% confidence interval, 1.05 to 1.63; P=0.02), or 24-hour hypertension (odds ratio, 1.39; 95% confidence interval, 1.08 to 1.81; P=0.01). Kidney length, expressed as SD score, was also significantly associated with nighttime hypertension (odds ratio, 1.23; 95% confidence interval, 1.06 to 1.42; P=0.10). Conclusions: These data indicate high prevalence of hypertension in children with autosomal dominant polycystic kidney disease starting at young ages.

1 August 2018 in The Journal of Pediatrics
Verified
Journal Article
Closed access
KBKathrin Burgmaier
Kathrin Burgmaier
KKKevin Kunzmann
Kevin Kunzmann
GAGema Ariceta
Gema Ariceta
CBCarsten Bergmann
Carsten Bergmann
ABAnja Katrin Buescher
Anja Katrin Buescher
RDRuhan Dusunsel
Ruhan Dusunsel

1 September 2019 in Kidney International Reports
Verified
Journal Article
Open access
SRStéphanie De Rechter
Stéphanie De Rechter
DBDetlef Bockenhauer
Detlef Bockenhauer
LGLisa M. Guay-Woodford
Lisa M. Guay-Woodford
ILIsaac Liu
Isaac Liu
Andrew MallettAndrew Mallett
Andrew Mallett
KZK. Zachwieja
K. Zachwieja
Autosomal dominant polycystic kidney disease (ADPKD) is the most common monogenic cause of renal failure. For several decades, ADPKD was regarded as an adult-onset disease. In the past decade, it has become more widely appreciated that the disease course begins in childhood. However, evidence-based guidelines on how to manage and approach children diagnosed with or at risk of ADPKD are lacking. Also, scoring systems to stratify patients into risk categories have been established only for adults. Overall, there are insufficient data on the clinical course during childhood. We therefore initiated the global ADPedKD project to establish a large international pediatric ADPKD cohort for deep characterization. Global ADPedKD is an international multicenter observational study focusing on childhood-diagnosed ADPKD. This collaborative project is based on interoperable Web-based databases, comprising 7 regional and independent but uniformly organized chapters, namely Africa, Asia, Australia, Europe, North America, South America, and the United Kingdom. In the database, a detailed basic data questionnaire, including genetics, is used in combination with data entry from follow-up visits, to provide both retrospective and prospective longitudinal data on clinical, radiologic, and laboratory findings, as well as therapeutic interventions. The global ADPedKD initiative aims to characterize in detail the most extensive international pediatric ADPKD cohort reported to date, providing evidence for the development of unified diagnostic, follow-up, and treatment recommendations regarding modifiable disease factors. Moreover, this registry will serve as a platform for the development of clinical and/or biochemical markers predicting the risk of early and progressive disease.

31 October 2019 in BMC Nephrology
Verified
Journal Article
Open access
PDF file
SPSvetlana Papizh
Svetlana Papizh
VSVictoria Serzhanova
Victoria Serzhanova
AFAlexandra Filatova
Alexandra Filatova
MSMikhail Skoblov
Mikhail Skoblov
VTVyacheslav Tabakov
Vyacheslav Tabakov
LPLarisa Prikhodina
Larisa Prikhodina
Background: Cystinosis is an autosomal recessive lysosomal storage disorder characterized by accumulation of cystine in lysosomes throughout the body. Cystinosis is caused by mutations in theCTNSgene that encodes the lysosomal cystine carrier protein cystinosin.CTNSmutations result in either complete absence or reduced cystine transporting function of the protein. The diagnosis of nephropathic cystinosis is generally based on measuring leukocyte cystine level, demonstration of corneal cystine crystals by the slit lamp examination and confirmed by genetic analysis of theCTNSgene.Case presentation: A boy born to consanguineous Caucasian parents had the characteristic clinical features of the infantile nephropathic cystinosis including renal Fanconi syndrome (polydipsia/polyuria, metabolic acidosis, hypokalemia, hypophosphatemia, low molecular weight proteinuria, glycosuria, cystine crystals in the cornea) and elevated WBC cystine levels. Initially we performed RFLP analysis of the common in the Northern European population 57-kb deletion of proband’s DNA, then a direct Sanger sequencing which revealed no mutations in the coding part of theCTNSgene. To confirm the diagnosis we performed RT-PCR analysis of total RNA obtained from patient-derived fibroblasts in combination with cDNA sequencing. This revealed the skipping of exon 4 and exon 5 in theCTNSin our patient. Therefore, we detected a novel 9-kb homozygous deletion in theCTNSgene at genomic DNA level, spanning region from intron 3 to intron 5. In order to identify the inheritance pattern of the deletion we analyzed DNA of proband’s mother and father. Both parents were found to be heterozygous carriers of theCTNSmutation.Conclusions: Analysis ofCTNSgene transcript allowed to identify a large homozygous deletion in the patient with infantile nephropathic cystinosis. Mutational detection at RNA level may be an efficient tool to establish the genetic defect in some cystinosis patients.

1 January 2023 in Nephrology and Dialysis
Verified
Journal Article
Closed access
PUPirogov Russian National Research Medical University
Pirogov Russian National Research Medical University
SPS.V. Papizh
S.V. Papizh
MSM.V. Shumikhina
M.V. Shumikhina
FHFilatov Children City Hospital
Filatov Children City Hospital
ATAnatoly Tiulpakov
Anatoly Tiulpakov
PEPirogov Russian National Research Medical University; Russian Academy of Medical Continuous Postgraduate Education
Pirogov Russian National Research Medical University; Russian Academy of Medical Continuous Postgraduate Education

8 February 2020 in Nephrology (Saint-Petersburg)
Verified
Journal Article
Closed access
PDF file
SPS. V. Papizh
S. V. Papizh
Hypercalcemia is a result of a wide range of hereditary and acquired conditions encountered by general physicians and pediatricians. Calcium participates in several key physiological functions, control of blood coagulation, bone calcification. Calcium homeostasis is tightly regulated by the interplay between absorption from the small intestine and renal tubular reabsorption, bone remodeling, and disposal through the gut and the kidney. These processes are regulated by local and circulating factors. The two main hormones influencing the homeostasis of calcium are PTH and calcitriol. Cancer-associated hypercalcemia and primary hyperparathyroidism are the most frequent causes of hypercalcemia in adults. In neonates and infants, one should look first at genetic and iatrogenic etiologies. The clinical manifestations of hypercalcemia in children are nonspecific due to damage to various organs and systems and depend on the degree of blood calcium level. Mild hypercalcemia is asymptomatic and often discovered during routine blood work. Moderate and severe hypercalcemia may cause cardiac arrhythmias, affect the nervous system. The differential diagnosis of the possible etiologies of hypercalcemia should start with the assessment of serum parathyroid hormone (PTH) concentration. The causes of hypercalcemia can be divided between PTH-mediated and non-PTH-mediated. Identification of the main causes of hypercalcemia contributes to the timely elimination of trigger factors, beginning of treatment, correction of nutrition and lifestyle. The article highlights physiological mechanisms of calcium homeostasis, clinical manifestations, diagnostic algorithms and treatment of hypercalcemia in children.